Introduction
The best characterized effect of vitamin D is on the small intestine and the bone. In the small intestine, vitamin D increases the absorption of calcium by increasing the expression of a specifi c calcium channel. In bone, vitamin D induces the differentiation of pre-osteoclasts into mature osteoclasts, ultimately promoting removal of calcium and phosphorus from the bone (1) (2) (3) .
Vitamin D enters the human body via two sources: exposure of the skin to sunlight and diet (1) . Solar radiation in the UVB waveband (wavelength, 290 to 315 nm) converts 7-dehydrocholesterol to previtamin D3 which is converted to vitamin D3 (1) (2) (3) (4) (5) . Natural dietary sources of vitamin D are wild fresh salmon (800 IU of D3 per 3.5 oz), cod liver oil (700 IU of D3 per 1 tps), sun-dried Shiitake mushrooms (1600 IU of D2 per 3.5 oz), fortifi ed foods such (6) . The discovery of vitamin D receptor (VDR) in lymphocytes, promyelocytes, macrophages, dendritic cells (DC) and islet cells of pancreas resulted in the idea that vitamin D had functions beyond calcium and phosphorus metabolism and that idea prompted investigations into noncalcemic actions of the vitamin D hormone (6, 7) . It has been shown that vitamin D has an important role in the regulation of the immune system. 1,25dihydroxyvitamin D3 (1,25 (OH)2D3) has been determined to suppress the development of autoimmune diseases. However, it does not have any effect on immunity to infectious organisms and other immune system mediated-diseases such as experimental asthma (7) . Dendritic cells, T helper 1 (Th1) and Th2 cells are direct targets of 1,25 (OH)2D3 (8). VDR is not found in appreciable amounts in the B lymphocyte, but in signifi cant concentrations in the T lymphocytes and macrophages (6, 9) . However, its highest concentration is in the immature immune cells of the thymus and the mature CD8 T lymphocytes. Immune cells are able to synthesize and secrete 1,25(OH)2D3 as they contain 1α-hydroxylase enzyme, which is necessary for the fi nal activation step in the conversion of vitamin D3 to the biological active form (10) . The 1α-hydroxylase enzyme in immune cells is identical to the renal enzyme, but regulation of its expression and activity is different. Whereas the renal enzyme is principally under the control of calcaemic and bone signals (such as parathyroid hormone and 1,25(OH)2D3, itself), the 1α-hydroxylase enzyme in the macrophage is primarily regulated by immune signals, interferon γ (IFN-γ) and toll-like receptor agonist which is the powerful stimulator of that enzyme (10) . Many studies have shown that some autoimmune diseases, such as systemic lupus erythematosus, rheumatoid arthritis, experimental autoimmune encephalomyelitis, type 1 diabetes, and infl ammatory bowel disease (IBD) can be not only prevented but also suppressed by 1.25(OH)2D3 (6) . Recent studies have shown signifi cant association of vitamin D defi ciency with obesity, type 2 diabetes mellitus and and Hashimoto's thyroiditis (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) . T cells is very low, but increases 5-fold after the activations of T cells (7, 26) . 1,25(OH)2D3 reduces the proliferation of purifi ed Th1 cells and the productions of IFN γ, IL-2, IL-5 and TNF-α, but, induces IL-4, and transforming growth factor (TGFB) synthesis, which is able to suppress infl ammatory T cell activity in Th2 cells (7, 26) . One of the evidences of that, a murine model of the human disease multiple sclerosis cannot be suppressed by 1,25(OH)2D3 in IL-4-defi cient mice (11) . The effects of 1,25(OH)2D3 on inhibition of the autoimmune diseases invivo has been shown to depend on IL-2 (27) and IL-4 secretions (28). 1,25(OH)2D3 decreases Th1 cell cytokines, but increases secretion of IL-4 which is one of the Th2 cell cytokines. When vitamin D signaling is absent, Th1 phenotype is the strongest phenotype in T cell compartment (7). Furthermore, Abe et al. and Tanaka et al. determined that vitamin D can not only inhibit promyelocytes proliferation, but induces their differentiation into monocytes as well (6, 29, 30) . Vitamin D or VDR defi cient hosts have high Th1 cell cytokine levels, although they have low levels of Th2 cell cytokines. When vitamin D signaling is absent, IBDs are more serious and asthma which is driven by Th2 cells does not develop. Results of recent studies suggest a model in which 1.25(OH)2D3 treatment for autoimmune diseases results in inhibition of Th1 cells proliferations and cytokine productions but induction of Th2 cells and Th2 cells cytokine synthesis (7, 31) . Moreover, 1.25(OH)2D3 inhibits DC differentiation and maturation, leading to down-regulated expression of MHC-II, co-stimulatory molecules and IL-12 and, enhances IL-10 production and promotes DC apoptosis. Because of those effects, 1,25(OH)2D3 inhibits DC-dependent T cell activation (32) . In vitro, it has been determined that 1.25 (OH)2D3 stimulates the phagocytosis and killing of bacteria by macrophages but suppresses the antigen presenting ability of those cells and DCs (33, 34) . IL-12 is produced by macrophages and DCs and is the major determinant of the direction in which the immune system will be activated, since it stimulates the development of CD4 Th1 cells and inhibits the development of Th2 cells. Inhibition of production of IL-12 by vitamin D invitro and a shift from Th1 to Th2 predominance can also be observed after in vivo administration of 1.25 (OH)2D3 (35, 36) . VDR is not found in appreciable amounts in the B lymphocyte. However, Chen et al. (37) have suggested that vitamin D might play a role in regulating antibody production. They have found that 1.25(OH)2D3 not only inhibits activated B cells proliferations but induces their apoptosis as well.
In conclusion, vitamin D stimulates the phagocytosis and killing of bacteria by macrophages, but suppresses Th1 cell activation by inhibiting the antigen presenting capacity of macrophages and DCs. At the second stage, vitamin D inhibits the secretion of Th1 cytokines and increases IL-4 secretion of Th2 cell. Moreover, vitamin D is suggested to have effects on B lymphocytes proliferation, apoptosis and antibody production.
